CDSCO Revises Testing Permission Process to Expedite Drug Approvals

The Central Drugs Standard Control Organization (CDSCO) has revised its testing permission norms to accelerate new drug approvals. Now, companies can begin laboratory testing immediately after application submission without waiting for detailed scrutiny. While initial technical checks are deferred, applicants must submit finalized regulatory specifications upfront, based on prevailing pharmacopoeial standards. Testing remains mandatory and is conducted at designated government laboratories, which submit reports to CDSCO for final approval consideration.